Microbot Medical (MBOT) Cost of Revenue (2010 - 2026)

Microbot Medical (MBOT) posted Cost of Revenue of $103000.0 for Q1 2026, up 77.09% on a QoQ basis from $58163.0 in Q3 2014.

Microbot Medical (MBOT) Cost of Revenue (2010 - 2026) Analysis & Trends

Microbot Medical's Cost of Revenue history runs 6 years deep, the most recent figure standing at $103000.0 for Q1 2026.

Quarterly Cost of Revenue changed N/A year-over-year to $103000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $326536.0 (changed N/A YoY) and the FY2025 annual result came in at $171000.0, down 3.93% from the prior year.
Cost of Revenue was $103000.0 for Q1 2026 at Microbot Medical, up from $58163.0 in the prior quarter.
Across five years, Cost of Revenue topped out at $103000.0 in Q1 2026 and bottomed at $103000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cost of Rev (Qtr)
1	Intuitive Surgical	126.32 Bn	121.10 Bn	1.96 Bn	931.90 Mn
2	Becton Dickinson	44.69 Bn	43.88 Bn	2.15 Bn	2.56 Bn
3	Alcon	32.80 Bn	31.14 Bn	1.53 Bn	18.00 Mn
4	Medline	32.72 Bn	30.49 Bn	1.84 Bn	5.51 Bn
5	Resmed	29.54 Bn	27.88 Bn	890.98 Mn	532.58 Mn
6	West Pharmaceutical Services	23.56 Bn	23.13 Bn	329.20 Mn	543.10 Mn
7	Solventum	14.00 Bn	13.44 Bn	1.10 Bn	11.00 Mn
8	Cooper Companies	13.75 Bn	13.61 Bn	735.40 Mn	346.10 Mn
9	Align Technology	12.03 Bn	10.97 Bn	736.59 Mn	303.50 Mn
10	Microbot Medical	116.52 Mn	47.48 Mn	2,000.00	103,000.00

Download Data